Data as of Dec 19
| +0.19 / +0.36%|
The 4 analysts offering 12-month price forecasts for Ligand Pharmaceuticals Inc have a median target of 82.00, with a high estimate of 116.00 and a low estimate of 46.00. The median estimate represents a +56.73% increase from the last price of 52.32.
The current consensus among 4 polled investment analysts is to Buy stock in Ligand Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.